MODULATION OF MULTIDRUG-RESISTANCE - AT THE THRESHOLD

[41] VERAPAMIL AND ADRIAMYCIN IN THE TREATMENT OF DRUG-RESISTANT OVARIAN-CANCER PATIENTS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 641 - 647

[42] A PHASE-I STUDY ON THE REVERSAL OF MULTIDRUG RESISTANCE (MDR) INVIVO - NIFEDIPINE PLUS ETOPOSIDE [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (02) : 267 - 270

[43] IMMUNOHISTOCHEMICAL DETECTION OF THE MULTIDRUG TRANSPORT PROTEIN P170 IN HUMAN NORMAL-TISSUES AND MALIGNANT-LYMPHOMAS [J]. HISTOPATHOLOGY, 1991, 19 (02) : 131 - 140

[44] MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) : 708 - 712

[45] VERAPAMIL REVERSAL OF CLINICAL DOXORUBICIN RESISTANCE IN HUMAN CANCER - A WILSHIRE-ONCOLOGY-MEDICAL-GROUP PILOT PHASE-I-II STUDY [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04): : 355 - 357

[46] PHASE II STUDY OF COMBINING VINBLASTINE AND CYCLOSPORINE-A TO CIRCUMVENT MULTIDRUG RESISTANCE IN RENAL-CELL CANCER [J]. ANNALS OF ONCOLOGY, 1991, 2 (04) : 305 - 306

[47] RONINSON IBE, 1991, MOL CELLULAR BIOL MU

[48] SALMON SE, 1991, BLOOD, V78, P44

[49] SCHEPER RJ, 1993, CANCER RES, V53, P1475

[50] FEASIBILITY OF USING QUININE, A POTENTIAL MULTIDRUG RESISTANCE REVERSING AGENT, IN COMBINATION WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE-LEUKEMIA [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) : 1730 - 1736

[41] VERAPAMIL AND ADRIAMYCIN IN THE TREATMENT OF DRUG-RESISTANT OVARIAN-CANCER PATIENTS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 641 - 647

[42] A PHASE-I STUDY ON THE REVERSAL OF MULTIDRUG RESISTANCE (MDR) INVIVO - NIFEDIPINE PLUS ETOPOSIDE [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (02) : 267 - 270

[43] IMMUNOHISTOCHEMICAL DETECTION OF THE MULTIDRUG TRANSPORT PROTEIN P170 IN HUMAN NORMAL-TISSUES AND MALIGNANT-LYMPHOMAS [J]. HISTOPATHOLOGY, 1991, 19 (02) : 131 - 140

[44] MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) : 708 - 712

[45] VERAPAMIL REVERSAL OF CLINICAL DOXORUBICIN RESISTANCE IN HUMAN CANCER - A WILSHIRE-ONCOLOGY-MEDICAL-GROUP PILOT PHASE-I-II STUDY [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04): : 355 - 357

[46] PHASE II STUDY OF COMBINING VINBLASTINE AND CYCLOSPORINE-A TO CIRCUMVENT MULTIDRUG RESISTANCE IN RENAL-CELL CANCER [J]. ANNALS OF ONCOLOGY, 1991, 2 (04) : 305 - 306

[47] RONINSON IBE, 1991, MOL CELLULAR BIOL MU

[48] SALMON SE, 1991, BLOOD, V78, P44

[49] SCHEPER RJ, 1993, CANCER RES, V53, P1475

[50] FEASIBILITY OF USING QUININE, A POTENTIAL MULTIDRUG RESISTANCE REVERSING AGENT, IN COMBINATION WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE-LEUKEMIA [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) : 1730 - 1736